Copyright
©The Author(s) 2022.
World J Meta-Anal. Jun 28, 2022; 10(3): 186-194
Published online Jun 28, 2022. doi: 10.13105/wjma.v10.i3.186
Published online Jun 28, 2022. doi: 10.13105/wjma.v10.i3.186
Ref. | Actual elevated ALT levels |
Kim et al[5] | Above normal levels |
Du et al[6] | Above normal levels |
Choi et al[7] | Above normal levels |
Wen et al[8] | ≥ 25 IU/L |
Hann et al[11] | Elevated |
Chen et al[12] | ≥ 45 IU/L |
Kumada et al[13] | Absence of persistently normal ALT levels |
Chen et al[14] | Above normal levels |
Ishiguro et al[15] | ≥ 30 IU/L |
Ando et al[16] | ≥ 23 IU/L |
Yamada et al[17] | ≥ 40 IU/L |
- Citation: Tarao K, Nozaki A, Komatsu H, Ideno N, Komatsu T, Ikeda T, Taguri M, Maeda S. Difference in incidence of developing hepatocellular carcinoma between hepatitis B virus-and hepatitis C virus-infected patients. World J Meta-Anal 2022; 10(3): 186-194
- URL: https://www.wjgnet.com/2308-3840/full/v10/i3/186.htm
- DOI: https://dx.doi.org/10.13105/wjma.v10.i3.186